Search Result "mi-dostaurin"
FLT3 Inhibition in Acute Myeloid Leukaemia â Current Knowledge and Future Prospects
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 513-531
Author(s): Francesca L. Hogan,Victoria Williams,Steven Knapper
Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 2 Year: 2011 Page: 217-225
Author(s): C. Annaloro, F. Onida, G. Saporiti, G. Lambertenghi Deliliers
C-KIT Signaling in Cancer Treatment
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 17 Year: 2014 Page: 2849-2880
Author(s): Karmen Stankov,Stevan Popovic,Momir Mikov
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):
Current Treatment Concepts of Philadelphia-Negative MPN
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 44-55
Author(s): D. Wolf, J. Rudzki, G. Gastl
Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 5 Year: 2011 Page: 638-666
Author(s): T. Robak, A. Szmigielska-Kaplon, A. Pluta, O. Grzybowska-Izydorczyk, A. Wolska, M. Czemerska, A Wierzbowska
Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 205-216
Author(s): Andreas Reiter, Christoph Walz, Nicholas C. P. Cross
Vascular Endothelial Growth Factor (VEGF) Inhibition - A Critical Review
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7 Issue: 2 Year: 2007 Page: 223-245
Author(s): Irina Sousa Moreira, Pedro Alexandrino Fernandes, Maria Joao Ramos